Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Its optimized 3PO derivative, PFK158, showed enhanced tolerability and reduced glycolytic flux in preclinical studies, was selected as the first-in-human, first-in-class PFKFB3 inhibitor, and has entered phase I clinical trials for advanced solid malignancies [256]
This distinction fundamentally shapes its pharmacokinetic profile, granting it properties (oral bioavailability, protease resistance, BBB penetration) that most neuropeptides lack
add your practice testimonials ethically.) GHK-Cu vs
For the kidneys, this means improved filtration efficiency, reduced scarring, and enhanced regenerative capacity, offering hope for managing conditions like chronic kidney disease and mitigating age-related organ decline (6)
US$ 22.93
US$ 23.36
US$ 21.88
US$ 20.09
US$ 24.97
US$ 25.00
US$ 27.98
